Cargando…
Oral modified release morphine for breathlessness in chronic heart failure: a randomized placebo‐controlled trial
AIMS: Morphine is shown to relieve chronic breathlessness in chronic obstructive pulmonary disease. There are no definitive data in people with heart failure. We aimed to determine the effectiveness and cost‐effectiveness of 12 weeks morphine therapy for the relief of chronic breathlessness in peopl...
Autores principales: | Johnson, Miriam J., Cockayne, Sarah, Currow, David C., Bell, Kerry, Hicks, Kate, Fairhurst, Caroline, Gabe, Rhian, Torgerson, David, Jefferson, Laura, Oxberry, Stephen, Ghosh, Justin, Hogg, Karen J., Murphy, Jeremy, Allgar, Victoria, Cleland, John G.F., Clark, Andrew L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989293/ https://www.ncbi.nlm.nih.gov/pubmed/31389157 http://dx.doi.org/10.1002/ehf2.12498 |
Ejemplares similares
-
Modified-release morphine or placebo for chronic breathlessness: the MABEL trial protocol
por: Date, Kathryn, et al.
Publicado: (2023) -
A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion And Morphine Sulfate (BEAMS) study protocol
por: Currow, David, et al.
Publicado: (2017) -
A feasibility cluster randomised controlled trial of a paramedic-administered breathlessness management intervention for acute-on-chronic breathlessness (BREATHE)
por: Northgraves, Matthew, et al.
Publicado: (2021) -
P009 The effects of low-dose morphine on sleep and breathlessness in chronic obstructive pulmonary disease
por: Altree, T, et al.
Publicado: (2022) -
Regular, low-dose methadone for reducing breathlessness in people experiencing or at risk of neurotoxic effects from morphine: A single-center case series
por: Sobanski, Piotr Z., et al.
Publicado: (2022)